All stock lists
Aspen Aerogels Inc (New York Stock Exchange:ASPN)
US · Delayed Price · Currency is USD
5.36-0.16 (-2.90%)
Insider Score
––Not scored
ASPN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ASPN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 49.85 M | 37.88 M | 41.34 M | 73.02 M | 78.02 M | 78.72 M |
| Revenue Growth (YoY) | -36.11 % | -51.88 % | -66.42 % | -37.77 % | -33.75 % | -16.70 % |
| Cost of Revenue | 46.59 M | 33.61 M | 64.27 M | 52.22 M | 52.71 M | 55.91 M |
| Gross Profit | 3.26 M | 4.28 M | -22.93 M | 20.80 M | 25.32 M | 22.81 M |
| SG&A Expense | 19.94 M | 21.96 M | 21.69 M | 20.09 M | 20.78 M | 21.42 M |
| R&D Expense | 3.19 M | 2.72 M | 2.79 M | 2.49 M | 3.79 M | 4.33 M |
| Operating Expenses | 23.14 M | 24.68 M | 24.48 M | 22.58 M | 24.58 M | 25.75 M |
| Operating Income | -19.87 M | -20.41 M | -47.41 M | -1.78 M | 738.00 K | -2.94 M |
| Pretax Income | -22.64 M | -23.94 M | -73.01 M | -5.74 M | -8.23 M | -300.17 M |
| Tax Provision | 619.00 K | -253.00 K | -97.00 K | 594.00 K | 821.00 K | 1.08 M |
| Net Income | -23.26 M | -23.69 M | -72.91 M | -6.33 M | -9.06 M | -301.25 M |
| EPS (Basic) | -0.28 | -0.29 | -0.88 | -0.08 | -0.11 | -3.67 |
| EPS (Diluted) | -0.28 | -0.29 | -0.88 | -0.08 | -0.11 | -3.67 |
| Shares Outstanding | 82.89 M | 82.74 M | 82.66 M | 82.40 M | 82.18 M | 82.07 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.